These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9809985)

  • 1. Size- and invasion-dependent increase in cyclooxygenase 2 levels in human colorectal carcinomas.
    Fujita T; Matsui M; Takaku K; Uetake H; Ichikawa W; Taketo MM; Sugihara K
    Cancer Res; 1998 Nov; 58(21):4823-6. PubMed ID: 9809985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma.
    Murata H; Kawano S; Tsuji S; Tsuji M; Sawaoka H; Kimura Y; Shiozaki H; Hori M
    Am J Gastroenterol; 1999 Feb; 94(2):451-5. PubMed ID: 10022645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis of colorectal cancer - role of gastrin and cyclooxygenase-2.
    Hartwich J; Konturek SJ; Pierzchalski P; Zuchowicz M; Konturek PC; Bielański W; Marlicz K; Starzyńska T; Ławniczak M
    Med Sci Monit; 2001; 7(6):1171-81. PubMed ID: 11687726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between Cyclooxygenase expression and colorectal adenoma characteristics.
    Einspahr JG; Krouse RS; Yochim JM; Danenberg PV; Danenberg KD; Bhattacharyya AK; Martínez ME; Alberts DS
    Cancer Res; 2003 Jul; 63(14):3891-3. PubMed ID: 12873979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COX-2: a molecular target for colorectal cancer prevention.
    Brown JR; DuBois RN
    J Clin Oncol; 2005 Apr; 23(12):2840-55. PubMed ID: 15837998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cyclooxygenase(COX)-2-inhibition in the prevention and treatment of colorectal carcinoma].
    Tuynman JB; Hulscher JB; Steller EP; van Lanschot JJ; Richel DJ
    Ned Tijdschr Geneeskd; 2003 Nov; 147(45):2207-12. PubMed ID: 14640057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COX-2, NSAIDs and human neoplasia. Part I: Colorectal neoplasms.
    Nasir A; Fernandez PM; Chughtai OR; Kaiser HE
    In Vivo; 2002; 16(6):501-9. PubMed ID: 12494894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase-2 expression is associated with increased size in human sporadic colorectal adenomas.
    Pisano C; Ottaiano A; Tatangelo F; Di Bonito M; Falanga M; Iaffaioli VR; Botti G; Pignata S; Acquaviva AM
    Anticancer Res; 2005; 25(3B):2065-8. PubMed ID: 16158946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoprevention of colorectal cancer through inhibition of cyclooxygenase-2.
    Dannenberg AJ; Zakim D
    Semin Oncol; 1999 Oct; 26(5):499-504. PubMed ID: 10528897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An introduction to aspirin, NSAids, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part II.
    Moyad MA
    Semin Urol Oncol; 2001 Nov; 19(4):306-16. PubMed ID: 11769882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.
    Gupta RA; Dubois RN
    Nat Rev Cancer; 2001 Oct; 1(1):11-21. PubMed ID: 11900248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric carcinoma.
    Ohno R; Yoshinaga K; Fujita T; Hasegawa K; Iseki H; Tsunozaki H; Ichikawa W; Nihei Z; Sugihara K
    Cancer; 2001 May; 91(10):1876-81. PubMed ID: 11346869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rationale and prospects for the use of cyclooxygenase-2 (COX-2) inhibitors in colorectal cancer].
    Buecher B; Heymann MF; Blottière HM
    Gastroenterol Clin Biol; 2001 Nov; 25(11):967-78. PubMed ID: 11845047
    [No Abstract]   [Full Text] [Related]  

  • 14. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.
    Lal G; Ash C; Hay K; Redston M; Kwong E; Hancock B; Mak T; Kargman S; Evans JF; Gallinger S
    Cancer Res; 2001 Aug; 61(16):6131-6. PubMed ID: 11507063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase-2 overexpression correlates with tumour recurrence, especially haematogenous metastasis, of colorectal cancer.
    Tomozawa S; Tsuno NH; Sunami E; Hatano K; Kitayama J; Osada T; Saito S; Tsuruo T; Shibata Y; Nagawa H
    Br J Cancer; 2000 Aug; 83(3):324-8. PubMed ID: 10917546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human colorectal adenomas demonstrate a size-dependent increase in epithelial cyclooxygenase-2 expression.
    Elder DJ; Baker JA; Banu NA; Moorghen M; Paraskeva C
    J Pathol; 2002 Dec; 198(4):428-34. PubMed ID: 12434411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of cyclooxygenase-1 and cyclooxygenase-2 in bronchial epithelium and nonsmall cell lung carcinoma.
    Hastürk S; Kemp B; Kalapurakal SK; Kurie JM; Hong WK; Lee JS
    Cancer; 2002 Feb; 94(4):1023-31. PubMed ID: 11920472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subepithelial myofibroblasts express cyclooxygenase-2 in colorectal tubular adenomas.
    Adegboyega PA; Ololade O; Saada J; Mifflin R; Di Mari JF; Powell DW
    Clin Cancer Res; 2004 Sep; 10(17):5870-9. PubMed ID: 15355919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs.
    Molina MA; Sitja-Arnau M; Lemoine MG; Frazier ML; Sinicrope FA
    Cancer Res; 1999 Sep; 59(17):4356-62. PubMed ID: 10485483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.
    Half E; Tang XM; Gwyn K; Sahin A; Wathen K; Sinicrope FA
    Cancer Res; 2002 Mar; 62(6):1676-81. PubMed ID: 11912139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.